BCL11B and Sepsis: The other entities in the complex frame centered around them in Figure 2 interaction map, appear to be seeking to counteract and oppose this activity i.e., there are a lot of directed inhibitory activities directed against them by other regulatory factors in pediatric sepsis e.g., BMX (229) and VSTM1 (116) etc. KLRK1 showed increased interaction with a variety of entities including BCL11B in pediatric sepsis.